This book explores post-trial access to drugs in developing countries, addressing ethical issues in global health inequalities and research. It analyzes obstacles to affordable drug access, including patent factors, and proposes a new paradigm for global health justice. The text covers intellectual property law, international regulations, and ethical debates.
